January 26th Lunch & Learn Event on Sjogren’s Syndrome PDF Print E-mail
Thursday, 07 January 2010 12:16
For those of you in the state of Texas, Northwest Rheumatology, a division of Northwest Diagnostic Clinic, will host a free Lunch & Learn event on Sjogren’s Sydrome: The Forgotten Disease on Tuesday, Jan. 26, from 11:45 a.m. – 1 p.m. at the South Montgomery County Woodlands Chamber of Commerce Board Room.

Dr. Tamar Brionez of Northwest Rheumatology will speak on the definition, symptoms and therapeutics of Sjogren’s Syndrome, a disease often undiagnosed or misdiagnosed due to symptoms that mimic other medical conditions. This Lunch & Learn is the second in a quarterly series that will address a variety of health topics.

“This is a great topic to discuss,” said Dr. Brionez. “The lunch will be very informative and I look forward to addressing the questions and concerns commonly associated with Sjogren’s Syndrome. I am excited to be the next speaker in this series.”

The event is free and open to the public. Reservations are required and must be made by Friday, Jan. 22.

With four physicians on staff, Northwest Rheumatology specializes in the treatment of Rheumatoid Arthritis, Scleroderma, Sjogren’s Syndrome, Psoriatic Arthritis, Lupus and other autoimmune diseases, as well as Osteoporosis and Osteoarthritis. With offices in The Woodlands and Houston, the clinic offers several areas of expertise including family practice, internal medicine and rheumatology, as well as on-site ancillary services such as CT, MRI, nuclear medicine, ultrasound, bone density testing, infusion and laboratory services.

For more information, do click here.
 
More articles :

» Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

Eric Hachulla, MD, PhD; David Launay, MD, PhD; Luc Mouthon, MD, PhD; Olivier Sitbon, MD, PhD; Alice Berezne, MD; Loïc Guillevin, MD; Pierre-Yves Hatron, MD; Ge´rald Simonneau, MD; Pierre Clerson, MD; and Marc Humbert, MD, PhD;Pulmonary arterial...

» Kidney Involvement In Scleroderma

Kidney disease is one of the manifestations of vascular, or blood vessel involvement, in .Other manifestations of vascular disease in Scleroderma include Raynaud's phenomenon, telangiectasia (dilated blood vessels, most common on the face and...

» Optical Coherence Tomography: The first Quantitative Imaging Biomarker for Scleroderma

Using the , manufactured in the UK by Michelson Diagnostics Ltd, scientists at the Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds have developed the first quantitative imaging biomarker for skin involvement in . Scleroderma...

» Musculoskeletal Rehabilitation in the Person with Scleroderma

Janet L. PoolePosted: 03/12/2010; Curr Opin Rheumatol. 2010;22(2):205 © 2010 Lippincott Williams & WilkinsAbstractPurpose of Review: The purpose of this review is to examine current evidence for the efficacy of rehabilitation techniques for...

» Sildenafil Reduces Raynaud's Frequency in Systemic Sclerosis Patients

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of in patients with limited cutaneous systemic sclerosis (lcSSc), also known as . The double-blind, placebo-controlled...

» Moves Toward Personalized Medicine for Scleroderma

researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study , an autoimmune disease for which there currently is no...